All In MedTech

Device Trial Radar · NCT02339974

Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER)

Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation HOVER Trial

Last checked: Nov 20, 2026Latest source record: Jun 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

15

Actual

Start

Jan 2015

Primary completion

Dec 2024

Study completion Jun 2025

Sponsor

Lead sponsor
Henry Ford Health SystemAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 16, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to determine the short term safety (\<30 days) and efficacy (6 months) of the heterotopic implantation of the Edwards-Sapien XT valve in the inferior vena cava for the treatment of severe tricuspid regurgitation in patients who are inoperable or at a very high surgical risk for tricuspid valve replacement.

Conditions

  • Tricuspid Regurgitation

Interventions

  • Heterotopic Implantation Of the Edwards-Sapien XT Transcatheter Valve in the Inferior VEna CavaDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Procedural SuccessTime frame: 30 days
  2. Individual Patient SuccessTime frame: 30 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Henry Ford Hosptial

    Detroit, Michigan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.